2024:

Simões D & Raben D, Moran AB, Imaz A, Stengaard AR, Raahauge A, Sullivan AK, Vaughan E, Brännström J, Baetselier ID, Platteau T, Casabona J, Del Amo J, on behalf of the 2023 HepHIV Conference Organising Committee and the EuroTEST Steering Committee. The HepHIV 2023 Madrid conference: A call to action for political leadership in reaching the sustainable development goals on earlier testing and linkage to care for HIV, viral hepatitis, and sexually transmitted infections. HIV Med. Epub 2024 Jun 24. https://doi.org/10.1111/hiv.13683

2023:

Raben D, Kahama CB, Combs L, Stengaard A, Rockstroh JK, Simões D, Collins B; European Testing Week Working Group and the EuroTEST Steering Committee. The use and impact of European Testing Week regional awareness campaigns to increase HIV and viral hepatitis testing coverage. HIV Med. 2024 Jan;25(1):154-160. Epub 2023 Sep 29. https://doi.org/10.1111/hiv.13544

2022:

Croxford S, Stengaard AR, Brännström J, Combs L, Dedes N, Girardi E, Grabar S, Kirk O, Kuchukhidze G, Lazarus JV, Noori T, Pharris A, Raben D, Rockstroh JK, Simões D, Sullivan AK, Van Beckhoven D, Delpech VC; EuroTEST HIV Late Diagnosis Definition Working Group. Late diagnosis of HIV: An updated consensus definition. HIV Med. 2022 Dec;23(11):1202-1208. Epub 2022 Nov 8. https://doi.org/10.1111/hiv.13425

Stengaard AR, Raben D, Leite RB, Seyler T, Lazarus JV, Lambert J, Collins B, Attawell K, Raahauge A, Rockstroh JK and Simões D on behalf of the 2021 HepHIV Conference Organising Committee and the EuroTEST Steering Committee. A call to action to reclaim focus on testing and early treatment for HIV, viral hepatitis, sexually transmitted infections and tuberculosis. Int J STD&AIDS. 2022;0(0):1-6.

2021:

Simões D, Matulionyté R, Stoniene L, Wysocki P, Kowalska J, Gasbarrini N, Cosmaro L, Blažić TN, Dišković A, Dominković Z, Jovovic I, Razmiene I, Maffeo M, Jakobsen SF. National multi-stakeholder meetings: a tool to support development of integrated policies and practices for testing and prevention of HIV, viral hepatitis, TB and STIs. BMC Infect Dis. 2021 Sep 13;21(Suppl 2):795.

Fernàndez-López L, Baros S, Niedźwiedzka-Stadnik M, Staneková DV, Rosińska M, Simic D, Jovanoic V, Hábeková M, Takáčová M, Wawer I, Wysocki P, Conway A, Klavs I, Casabona J. Integration of community-based testing data into national HIV surveillance in Poland, Serbia and Slovakia within the framework of INTEGRATE project. BMC Infect Dis. 2021 Sep 13;21(Suppl 2):800.

Fernàndez-López L, Klavs I, Conway A, Kustec T, Serdt M, Baros S, Staneková DV, Lemsalu L, Wawer I, Wysocki P, Casabona J. Recommendations for collection and integration of community-based testing and linkage to care data into national surveillance, monitoring and evaluation systems for HIV, viral hepatitis and sexually transmitted infections: results from the INTEGRATE Joint Action. BMC Infect Dis. 2021 Sep 13;21(Suppl 2):794.

Kall M, Fresán U, Guy D, Brown G, Burgui C, Castilla J, Grecu VI, Dumitrescu F, Delpech V, Lazarus JV. Quality of life in people living with HIV in Romania and Spain. BMC Infect Dis. 2021 Sep 13;21(Suppl 2):898.

Glaspy S, Cosmaro L, Botsi C, Stamou M, Giannopoulou M, Isari AM, Downey C, Hugh TM, Avramovic G, Lambert JS. Integrating partner notification and contact tracing services across Europe: findings from the Integrate project. BMC Infect Dis. 2021 Sep 13;21(Suppl 2):796.

Kakalou C, Polychronidou E, Drosou V, Dimitriadis VK, Dermaris T, Kordonias R, Papaprodromou A, Tsirelis T, Maramis C, Votis K, Tzovaras D, Savarino D, Maffeo M, Jasic N, Nemeth-Blažić T, Dominković Z, Pogledić D, Jovovic I, Simkunaite-Zazecke A, Stoniene L, Sammut A, Cosmaro L, Natsiavas P. RiskRadar: development and pilot results of a technical intervention targeting combination prevention regarding HIV, viral hepatitis, sexually transmitted infections and tuberculosis. BMC Infect Dis. 2021 Sep 13;21(Suppl 2):866.

Nash SG, Maffeo M, Likatavicius G, Cosmaro L, Rudaitis K, Lapsinov A, Enayat Q, Delpech V, Kall M. Acceptability and usability of HIV self-tests in two European countries: findings from surveys of clients at non-governmental organisations in Lithuania and Italy. BMC Infect Dis. 2021 Sep 13;21(Suppl 2):844

Matulionytė R, Jakobsen ML, Grecu VI, Grigaitiene J, Raudonis T, Stoniene L, Olteanu M, de la Mora L, Raben D, Sullivan AK. Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain. BMC Infect Dis. 2021 Sep 13;21(Suppl 2):845.

Gasbarrini N, Dubravić D, Combs L, Dišković A, Ankiersztejn-Bartczak M, Colaiaco F, Wawer I, Wysocki P, Rosińska M, Marzec-Boguslawska A, Collins B, Simões D, Jakobsen ML, Raben D. Increasing integrated testing in community settings through interventions for change, including the Spring European Testing Week. BMC Infect Dis. 2021 Sep 13;21(Suppl 2):874.

Raben D, Casabona J, Cosmaro L, Gasbarrini N, Lambert JS, Glapsy S, Kakalou C, Maffeo M, Mommi M, Corradini G, Klavs I, Kurbatova A, Wawer I, Wysocki P, Raahauge A, Jakobsen SF, Lazarus JV, Sullivan A, Kall M, Hedrich D, Johnson CC, Seguy NS, Simões D, Delpech V. Lessons learned from the first European project on the integration of infectious diseases in testing services, data collection and country responses. BMC Infect Dis. 2021 Sep 13;21(Suppl 2):690.

Stengaard AR, Combs L, Supervie V, Croxford S, Desai S, Sullivan AK, Jakobsen SF, Santos Q, Simões D, Casabona J, Lazarus JV, Wit JBF, Amort FM, Pharris A, Nerlander L*, Raben D*.  HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019. Euro Surveill. 2021;26(47):pii=2100044 

Raben D, Sullivan AK. Implementation of indicator condition guided HIV testing still lagging behind the evidence. EClinicalMedicine. 2021 May 29;36:100918.

2020:

Simoes D, Stengaard AR, Combs L, Raben D, The EuroTEST COVID-19 impact assessment consortium of partners. Radid communication. Impact of the COVID-19 pandemic on testing services for HIV, viral hepatitis and sexually transmitted infections in the WHO European Region, March to August 2020. Euro Surveill. 2020;25(47). (PDF)

Raben D, Hoekstra M, Combs L, Sullivan AK, Lazarus JV, Lambert JS, Simões D, Streinu‐Cercel A, Rockstroh JK on behalf of the HepHIV Conference Organizing Committee, the EuroTEST Steering Committee, INTEGRATE Steering Committee. A call to action toward integrated testing and earlier care for viral hepatitis, HIV, STIs and TB. HIV Medicine, April 2020.

2019:

Raben D, Sullivan AK, Mocroft A, Kutsyna G, Hadžiosmanović V, Vassilenko A, Chkhartisvili N, Mitsura V, Pedersen C, Anderson J, Begovac J, Dragsted UB, Bertisch B, Grzeszczuk A, Minton J, Necsoi VC, Kitchen M, Ajana F, Sokhan A, Comi L, Farazmand P, Pesut D, De Wit S, Gatell JM, Gazzard B, d’Arminio Monforte A, Rockstroh JK, Yazdanpanah Y, Champenois K, Jakobsen ML, Lundgren JD, on behalf of the HIDES Study Group. Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study – 2012 – 2015.  

K Rüütel, L Lemsalu, S Lätt, J Epštein, on behalf of OptTEST by HiE. Missed opportunities for HIV testing in people diagnosed with HIV, Estonia, 2014 to 2015.

Combs L, Daamen C, Kifetew C. Going new ways to end HIV: reaching men who have sex with men through a community, business, and public health partnership to increase HIV testing in Europe. RECS. Suplemento 2, 2019.Comunicación y VIH. doi.org/10.20318/recs.2019.4596

Desai S, Tavoschi L, Sullivan AK, Combs L, Raben D, Delpech V, Jakobsen SF, Amato‐Gauci AJ, Croxford S. HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review. HIV Med. 2019 Nov 14. doi: 10.1111/hiv.12809.

Croxford S, Tavoschi L, Sullivan AK, Combs L, Raben D, Delpech V, Jakobsen SF, Amato-Gauci AJ, Desai S. HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance. HIV Med. 2019 Nov 14. doi: 10.1111/hiv.12809.

2018:

European Centre for Disease Prevention and Control. Public health guidance on HIV, hepatitis B and C testing in the EU/EEA – An integrated approach. Stockholm: ECDC; 2018.

Dara M, Gavry ZT, Mansfeld M (Eds). European Testing Week: A regional initiative to advocate and promote testing for viral hepatitis and HIV. In: Compendium of good practices in the health sector response to HIV in the WHO European Region. Copenhagen: WHO; 2018.

SF Jakobsen , D Raben, I Sperle, JV Lazarus , C James, L Mendao, J de Wit, T Platteau , A-I von Lingen, GM Corbelli, C Antoniadi, J Casabona, B West, J Rockstroh and V Delpech on behalf of the HIV in Europe Steering Committee. Scale-up of HIV self-testing. Letter to the Editor: HIV Medicine (May 2018)

Outcomes of the HepHIV 2017 Malta Conference: Joining Forces for Earlier Diagnosis and Linkage to Care Across Europe HIV Medicine (Special Issue, February, 2018)

2017:

Sullivan AK,Sperle I,Raben D,Amato-Gauci AJ, Lundgren JD, Yazdanpanah Y, Jakobsen SF,Tavoschi L. HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European Centre for Disease Prevention and Control (ECDC)’s 2010 HIV testing guidance. Eurosurveillance 2017;22(48)

Mauss S, Pol S, Buti M, Duffell E, Gore C, Lazarus JV, der Grient HL, Lundgren J, Mozalevskis A, Raben D, Schatz E, Wiktor S, Rockstroh JK; European consensus working group on late presentation for Viral Hepatitis Care. Late presentation of chronic viral hepatitis for medical care: a consensus definition. BMC Medicine (2017) 15:92

J Kowalska, Grzeszczuk A, Pyziak-Kowalska K et al. Shaping the HIV epidemic in Poland – proceedings from the first Polish workshop on cascade of care in HIV. HIV AIDS Rev 2017; 16.

2016:

Mauss S, et al. Late presentation of chronic viral hepatitis for medical care: a consensus definition. BMC Medicine.

Lord E, et al. Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions. HIV Medicine (2016)

Lazarus JV et al. Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe. Croatian Medical Journal 2016 Oct 31; 57(5):442-456.

Bell SA, Delpech V, Raben D, Casabona J, Tsereteli N, de Wit J. HIV pre-test information, discussion or counselling? A review of guidance relevant to the WHO European Region. Int J STD AIDS. 2016;27(2):97–104.

Bell SA, Casabona J, Tsereteli N, Raben D, de Wit J. HIV pre-test practices: an online survey examining perceptions of informed consent and pre-test information delivery in health care settings across the WHO European Region.  Int J STD AIDS. 2016:28(0): 558-563.

Bell SA, Casabona J, Tsereteli N, Raben D, de Wit J. HIV post-test practices: an online survey examining perceived delivery of HIV test results, post-test discussion and referral in healthcare settings across the WHO European region. Sexual Health. 2016: 13(3): 205-212.

Lazarus JV, Sperle I, Spina A, Rockstroh JK. Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe. Croat Med J. 2016 Oct 31;57(5):442-456.

2015:

Bell SA, Delpech V, Casabona J, Tsereteli N, de Wit J. Delivery of HIV test results, post-test discussion and referral in health care settings: a review of guidance for European countries. HIV Medicine. 2015: 16(10): 620-627.

Raben D, Mocroft A, Rayment M, Mitsura VM, Hadziosmanovic V, Sthoeger ZM, Palfreeman A, Morris S, Kutsyna G, Vassilenko A, Minton J, Necsoi C, Estrada VP, Grzeszczuk A, Johansson VS, Begovac J, Ong EL, Cabié A, Ajana F, Celesia BM, Maltez F, Kitchen M, Comi L, Dragsted UB, Clumeck N, Gatell J, Gazzard B, d'Arminio Monforte A, Rockstroh J, Yazdanpanah Y, Champenois K, Jakobsen ML, Sullivan A, Lundgren JD; HIDES Audit Study Group.. Auditing: Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study. PLoS One. 2015 Nov 11;10(11):e0140845. doi: 10.1371/journal.pone.0140845.

2013:

Lazarus JV, Hoekstra M, Raben D, Delpech V, Coenen T, Lundgren JD; HIV in Europe Initiative Steering Committee. The case for indicator condition-guided HIV screening. HIV Med. 2013 Aug;14(7):445-8. doi: 10.1111/hiv.12022

Mocroft A, Lundgren JD, Sabin ML, Monforte Ad, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord. Risk Factors and Outcomes for Late Presentation for HIV- positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013;10(9):e1001510. doi: 10.1371/journal.pmed.1001510. 

Feasibility and Effectiveness of Indicator Condition Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study)
Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, Leon A, Begovac J, Brinkman K, Zangerle R, Grzeszczuk A, Vassilenko A, Hadziosmanovic V, Krasnov M, Sönnerborg A, Clumeck N, Gatell J, Gazzard B, Monforte Ad, Rockstroh J, Lundgren JD. PLoS One. 2013;8(1):e52845. doi: 10.1371/journal.pone.0052845

2011:

Lazarus JV, Jürgens R, Weait M, Phillips A, Hows J, Gatell J, Coenen T, Sönnerborg A, Raben D, Lundgren JD. Overcoming obstacles to late presentation for HIV infection in Europe. HIV Med. 2011 Apr;12(4):246-9. doi: 10.1111/j.1468-1293.2010.00872.x.

Phillips A, et al. for the Working Group on Estimation of HIV Prevalence in Europe. HIV in hiding: methods and data requirements for the estimation of the number of people living with undiagnosed HIV.. AIDS. 2011 May 15;25(8):1017-23. doi: 10.1097/QAD.0b013e3283467087.

Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, Girardi E, Johnson M, Kirk O, Lundgren J, Mocroft A, D'Arminio Monforte A, Phillips A, Raben D, Rockstroh JK, Sabin C, Sönnerborg A, De Wolf F; European Late Presenter Consensus Working Group. Late presentation of HIV infection: a consensus definition. HIV Med. 2011 Jan;12(1):61-4. doi: 10.1111/j.1468-1293.2010.00857.x.

Evidence and practice of HIV counselling
HIV testing services summary report (PDF)
HIV pre-test practices (PDF)
HIV post-test practices (PDF)
Delivery of HIV test results, post-test discussion and referral in health care settings (PDF)
Delivery HIV pre-test information (PDF)

2010:
Lazarus JV, Jürgens R, Weait M, Phillips A, Hows J, Gatell J, Coenen T, Sönnerborg A, Raben D and JD Lundgren. Overcoming obstacles to late presentation for HIV in Europe. HIV Medicine, Published Online: 29 Aug 2010.

European late presenter working group: Late presentation of HIV infection: A consensus definition, HIV Medicine, A Antinori et al. Published Online: 17 Jun 2010